Orange County
Overview
The Orange County office has a winning track record for handling the most complex matters for our clients. Lawyers in the office represent local, national and international clients in antitrust, complex commercial litigation, recovery, environmental, intellectual property, white collar & regulatory enforcement, and transactional matters. Clients of the Orange County office include Fortune 500, middle market, and start-up companies across sectors, ranging from technology and transportation to health care and hospitality.
Click here to explore opportunities in our Orange County office.
Crowell ’s Orange County office has had a long-standing commitment to the surrounding community. A number of our attorneys serve as board members for local organizations, such as Project Youth OC, Orange County Bar Association–Diversity Equity & Inclusion Committee, Lavender Bar Association, Public Law Center, Thurgood Marshall Bar Association, United Way, Elder Law & Disability Rights Center, Western Center on Law and Poverty, Public Law Center, and Community Legal Aid SoCal, among many others.
In addition to our pro bono efforts, our office is passionate about supporting the education of youth in Orange County. We also established the first endowed diversity scholarship with the University of California, Irvine School of Law (UCI Law). This scholarship will have the effective impact of an endowment in excess of $1 million dollars in an effort to help create a legal community that reflects the identities and backgrounds of the world at large. Additionally, the Orange County office works with Project Youth, where we mentor high school students and help guide them in making positive choices, building the foundation for a lifetime of opportunity and success.
We know that diversity of thought and talent is a catalyst to providing the best advice and service to our clients and the firm is committed to fostering a culture of inclusivity. Our Orange County office is resident to the first diverse female chair of Crowell’s executive committee, who was herself a 2016 fellow of the Leadership Council on Legal Diversity (LCLD). Our team includes many diverse lawyers who are leaders within the firm and the bar, such as a director for the Orange County Asian American Bar Association, a founding board member of the Orange County Lavender Bar Association, a board member-at-large at the Thurgood Marshall Bar Association, and chair of the firm’s LGBTQ + Affinity group. Many of our Orange County attorneys are also active members in the Hispanic National Bar Association, National Asian Pacific American Bar Association (NAPABA), Orange County Coalition for Diversity in the Law, and Orange County Equality Coalition. Lawyers and professional staff in the Orange County office also established and spearheaded Crowell’s Social Justice Conversations, which are regular discussions focused on better understanding the experiences of marginalized, diverse groups in America—an initiative that has since expanded to several other Crowell offices in the U.S.
Contacts
Managing Partner
She/Her/Hers
Insights
Client Alert | 4 min read | 04.18.24
Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2]
Client Alert | 3 min read | 04.02.24
Insights
Professionals
Insights
Client Alert | 4 min read | 04.18.24
Following federal lawmakers’ initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs’ prices. Drug affordability for consumers is a top priority for federal and state lawmakers and regulators because it is a bipartisan issue that directly impacts consumers’ wallets. With negotiations between the federal government and drug manufacturers over 10 drugs’ prices for Medicare beneficiaries well underway under the Inflation Reduction Act, 11 states, including Maryland and Colorado, have created drug affordability review boards to more directly tackle rising prices for both brand and generic drugs.[1] And another 12 states have pending legislation to create these boards.[2]
Client Alert | 3 min read | 04.02.24
